ArticleFrontiers in psychiatry2025
Global, regional, and national burden of premenstrual syndrome from 1990 to 2021 and projections to 2050: an analysis based on the 2021 Global Burden of Disease study.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Acceptability of ambulatory surgery provided in freestanding ambulatory surgical centers and its associated factors among surgical healthcare providers in Uganda.Surgical endoscopy · 2026Article
- Global Burden of Premenstrual Syndrome and Uterine Fibroids in Women of Reproductive Age (1990-2023) and Projections to 2050: An Analysis of the Global Burden of Disease Study 2023.Health science reports · 2026Article
- Genetic predisposition for depression, psychosocial and behavioural factors and premenstrual symptoms: a cross-sectional study among young women in China.BMC medicine · 2026Article
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Premenstrual syndrome (PMS) imposes significant psychological and mental health burdens on women's reproductive and general well-being. Disparities in the recognition and reporting of PMS symptoms exist across different regions, influenced by social, cultural, and economic inequalities. This study aims to inform the development of future resource allocation, and ultimately safeguard women's reproductive mental health. Methods: Utilizing data from the Global Burden of Disease (GBD) 2021 database, we employed Joinpoint regression analysis to examine trends in the burden of PMS from 1990 to 2021, and investigated the impact of the Socio-demographic Index (SDI) on the PMS burden. Additionally, we compared the age distribution characteristics of prevalent PMS cases in 1990 and 2021 and projected the burden to 2050 using the Bayesian Age-Period-Cohort (BAPC) model. Results: Despite fluctuations, the global burden of PMS was higher in 2021 compared to 1990. The low-middle SDI region consistently had the highest age-standardized prevalence rate (ASPR) and age-standardized years lived with disability (YLDs) rate, which continued to rise; the middle SDI region followed. The high SDI region generally had the lightest burden for most of the period. Among the five SDI regions, only the high-middle SDI region showed a decrease in burden in 2021 compared to 2019. ASPR and age-standardized YLDs rate demonstrated an initial increase followed by a decrease with rising SDI levels. The age distribution of prevalent PMS cases shifted: the peak prevalence moved from the 20-24 age group in 1990 to the 35-39 age group in 2021, while the 40-44 age group was followed by 35-39 in the the same year. Projections showed a declining trend in the global burden of PMS by 2050. Conclusion: Overall, the global burden of PMS has shown an increasing trend from 1990 to 2021. The burden in low SDI regions may be substantially underestimated, influenced by social, cultural, and economic factors. In socioeconomically disadvantaged regions, attention to menstrual-related mental health, scientific diet, and allocation of healthcare resources require further optimization. In fact, mental health of women aged 35-44 should be emphasized throughout their lifespans, for a better reproductive and general well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.